Modulation of Inhibition of Return by the Dopamine D2 Receptor Agonist Bromocriptine Depends on Individual DAT1 Genotype

Modulation of Striatal Projection Systems by Dopamine

(2011) Charles R. Gerfen et al.   Annual Review of Neuroscience

Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control

(2011) Roshan Cools et al.   BIOLOGICAL PSYCHIATRY

The Dopamine Agonist Bromocriptine Differentially Affects Fronto-Striatal Functional Connectivity During Working Memory

(2011) Deanna L. Wallace et al.   Frontiers in Human Neuroscience

Cholinergic Enhancement Increases the Effects of Voluntary Attention but Does Not Affect Involuntary Attention

(2010) Ariel Rokem et al.   NEUROPSYCHOPHARMACOLOGY

Striatal Dopamine Predicts Outcome-Specific Reversal Learning and Its Sensitivity to Dopaminergic Drug Administration

(2009) R. Cools et al.   JOURNAL OF NEUROSCIENCE

The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety

(2009) D.J. Heal et al.   NEUROPHARMACOLOGY

Space-based but not object-based inhibition of return is impaired in Parkinson's disease

(2009) Katherine L. Possin et al.   NEUROPSYCHOLOGIA

Recreational use of cocaine eliminates inhibition of return.

(2009) Lorenza S. Colzato et al.   NEUROPSYCHOLOGY

A review of Parkinson's disease

(2008) C. A. Davie   BRITISH MEDICAL BULLETIN

Working Memory Capacity Predicts Dopamine Synthesis Capacity in the Human Striatum

(2008) R. Cools et al.   JOURNAL OF NEUROSCIENCE